Dexxon Holdings Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 3,796 shares at $7.70 ($29K) on 2019-05-24, disclosed to the SEC on 2019-05-29.
Scheduled purchase ($29k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UROV | BUY | 2019-05-20 | $82K | — | Filing → |
| AXON | BUY | 2019-03-19 | $20.0M | — | Filing → |
| AXON | BUY | 2018-12-20 | $10.0M | — | Filing → |